Sleep-disordered Breathing Clinical Trial
Official title:
Sleep-disordered Breathing in Infants With Myelomeningocele
Verified date | April 2024 |
Source | University of Michigan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study aims to determine whether the risk for sleep-disordered breathing in infants with myelomeningocele (a severe form of spina bifida) differs among those who underwent fetal vs. postnatal surgery, and to examine the link between sleep-disordered breathing and neurodevelopment.
Status | Active, not recruiting |
Enrollment | 173 |
Est. completion date | July 2026 |
Est. primary completion date | April 25, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 2 Years |
Eligibility | Inclusion Criteria: neonates with myelomeningocele who are cared for at a study center NICU are eligible to participate after myelomeningocele repair. Exclusion Criteria: - born at <30 weeks gestation - congenital anomalies that would predispose to sleep-disordered breathing (e.g. micrognathia) - confirmed or suspected genetic syndromes that alter developmental outcomes |
Country | Name | City | State |
---|---|---|---|
United States | Mott Children's Hospital | Ann Arbor | Michigan |
United States | Children's Hospital Colorado | Aurora | Colorado |
United States | University of Alabama at Birmingham | Birmingham | Alabama |
United States | Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio |
United States | University of Texas-Houston | Houston | Texas |
United States | Children's Minnesota | Minneapolis | Minnesota |
United States | Children's Hospital of Philadelphia | Philadelphia | Pennsylvania |
United States | Mayo Clinic | Rochester | Minnesota |
United States | Washington University | Saint Louis | Missouri |
Lead Sponsor | Collaborator |
---|---|
University of Michigan | National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of neonatal sleep-disordered breathing (SDB) in infants who had fetal versus postnatal myelomeningocele repair. | Neonatal sleep studies will be used to capture neonatal Apnea-Hypopnea Index (AHI), the most widely accepted summary measure of sleep-disordered breathing severity for newborns who had fetal (prenatal) versus postnatal myelomeningocele repair. | 35-42 weeks postmenstrual age | |
Secondary | Association between neonatal sleep-disordered breathing and neurodevelopmental outcomes at 2 years of age for infants with myelomeningocele. | Bayley-IV developmental exams will be performed on all subjects around 2-years of age. The Bayley-IV will determine if the subject's level of thinking, language, and motor skills are similar to the level of most children their age. Our assessment will be based off the Cognitive Subscale Score. It has a range from 40-160 with a mean score of 100 and standard deviation of 15. The scores will analyzed with regression models and general linear models to see if there is an association between Neonatal AHI for infants with myelomeningocele, fetal vs. postnatal myelomeningocele repairs, and neurodevelopmental outcomes. | 22-26 months corrected age | |
Secondary | Persistence of sleep-disordered breathing at 2-years of age | Sleep studies will be performed at 2-years of age to capture AHI and compare to neonatal AHI for neonates who had fetal versus postnatal myelomeningocele repair. | 22-26 months corrected age |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05547477 -
Continuous EMG Measurements in Children With Asthma During Sleep
|
||
Completed |
NCT01503164 -
Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism
|
N/A | |
Recruiting |
NCT00863421 -
Sleep Disordered Breathing in Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT00841906 -
Alice PDx User/Validation Extended Trial
|
N/A | |
Not yet recruiting |
NCT05462834 -
Impact of Nocturnal Hypoxemia on Glucose in High Altitude Sleep Disordered Breathing
|
N/A | |
Recruiting |
NCT01785199 -
Effects of Head Elevation by a Bed on Sleep-disordered Breathing
|
Phase 1 | |
Recruiting |
NCT06043830 -
Managing Opioid Related Sleep Apnea With Acetazolamide
|
Phase 2 | |
Recruiting |
NCT04351698 -
SMILES: Study of Montelukast in Sickle Cell Disease
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05643352 -
Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring
|
N/A | |
Recruiting |
NCT03142022 -
Sleep-disordered Breathing After Solid Organ Transplantation
|
||
Recruiting |
NCT05336890 -
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
|
||
Recruiting |
NCT05466864 -
Screening of OSA in Hospitalized Stroke Patients Using BSP
|
N/A | |
Recruiting |
NCT05661747 -
Dental Appliance to Treat SDB in Children
|
Phase 4 | |
Completed |
NCT02855515 -
Drug-Induced Sleep Endoscopy for the Optimisation of Treatment of Patients With Obstruction Sleep Apnoea
|
N/A | |
Recruiting |
NCT05575401 -
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
|
N/A | |
Completed |
NCT02923505 -
Effect of Positive Airway Pressure Therapy on Hospitalization and Mortality in SDB Patients With Comorbid Chronic Obstructive Pulmonary Disease (COPD) or/and Heart Failure (HF)
|
||
Completed |
NCT06154577 -
Tongue Morphology and Posterior Airway Space as Predictors of Response in Patientswith Hypoglossal Nerve Stimulation Therapy
|
||
Recruiting |
NCT04331821 -
READ-ASV Registry - Phase II
|
||
Completed |
NCT02830074 -
Treatment of Sleep-disordered Breathing in Patients With SCI
|
N/A | |
Completed |
NCT02245659 -
Effect of CPAP Treatment on Glycemic Control in Gestational Diabetes: A Pilot Randomized-Controlled Trial
|
N/A |